hims & hers has acquired Eucalyptus for $1.1 billion. Eucalyptus operates a trusted group of digital healthcare clinics on its telehealth platform, encompassing specialized brands such as Pilot for men’s health, Kin for fertility, Software for dermatology, and Juniper for weight loss and menopause. Eucalyptus’s mission is to deliver high-touch, high-quality healthcare to patients globally by empowering practitioners with technology. Since its inception in 2019, the company has facilitated over one million consultations across Australia, the UK, and Germany, emphasizing accessible, stigma-free experiences and continuous support, alongside a strong record of patient safety.
This acquisition marks a significant strategic expansion for hims & hers, extending its reach into established international markets including Australia, the UK, and Germany. The integration of Eucalyptus’s diverse and specialized telehealth clinics is expected to broaden hims & hers’ service portfolio, adding expertise in areas like fertility, advanced dermatology, and comprehensive weight management and menopause care. The move is designed to capitalize on the growing global demand for accessible digital health solutions, leveraging Eucalyptus’s proven operational model and international patient base.
The combination of these two digital healthcare providers is anticipated to generate substantial synergies, including enhanced technological capabilities, expanded practitioner networks, and a more diversified revenue stream. By bringing together Eucalyptus’s specialized care pathways and international footprint with hims & hers’ existing platform, the combined entity aims to create a more robust and comprehensive telehealth offering. This strategic alignment is set to reinforce a shared commitment to breaking down barriers to better health, delivering an expanded range of high-quality digital health services to a wider global audience.